# Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)

> **NCT05294744** · NA · RECRUITING · sponsor: **Bioaraba Health Research Institute** · enrollment: 390 (estimated)

## Conditions studied

- Alcoholic Hepatitis

## Interventions

- **DRUG:** N-acetylcysteine

## Key facts

- **NCT ID:** NCT05294744
- **Lead sponsor:** Bioaraba Health Research Institute
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-07
- **Primary completion:** 2026-07
- **Final completion:** 2026-12
- **Target enrollment:** 390 (ESTIMATED)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05294744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05294744, "Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05294744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*